INTRODUCTION
Mitochondrial distribution and transport are central to many cellular functions, including cell differentiation (Chada and Hollenbeck, 2004) , cell division to ensure proper inheritance (Yaffe, 1999) , ATP supply at the local sites of demand, and Ca 2+ buffering for intracellular Ca 2+ homeostasis (Yi et al., 2004; Zucker, 1999) . Strategic intracellular mitochondrial distribution depends on the movement of mitochondria, which is mediated by a complex of proteins first identified in genetic screens performed in Drosophila melanogaster. The anterograde mitochondrial transport in axons is abolished in either Milton or Miro mutants (Guo et al., 2005; Stowers et al., 2002) ; Milton co-immunoprecipitates with and attaches kinesin to mitochondria through Miro, an outer mitochondrial membrane (OMM) protein (Glater et al., 2006) . In mammals, mitochondrial motility is mediated by trafficking kinesin proteins (Trak1 and Trak2, Milton homologs) that work as adaptors between Miro1 and Miro2 (Miro homologs) and dynein and kinesin motor proteins to allow movement of the organelles along the microtubules (Brickley et al., 2005; Fransson et al., 2006; Hirokawa et al., 1991; MacAskill et al., 2009a; Nguyen et al., 2014) .
In the last decade, the mitochondrial motility machinery has been determined, but the signaling mechanisms underlying the specificity and the spatio-temporal control of the mitochondrial movements remained elusive. Mitochondrial membrane potential (Dc m ) is central to mitochondrial movement because agents that depolarize mitochondria inhibit mitochondrial transport (Rintoul et al., 2003; Vanden Berghe et al., 2004; Yi et al., 2004) . First, mitochondria with high Dc m were shown to preferentially move anterogradely while depolarized ones move retrogradely (Miller and Sheetz, 2004) , but later studies showed no directionality difference between the two populations Verburg and Hollenbeck, 2008) . Changes in ATP/ADP likely affect movements because ADP slowly dissociates from the motor to act like an inhibitor. We and others previously showed that motility is regulated by the cytoplasmic Ca 2+ concentration ([Ca 2+ ] c ), providing the basis for a homeostatic circuit in which the organelles decrease their movements along microtubules at the sites of high [Ca 2+ ] c to locally buffer Ca 2+ and contribute to ATP supply (Brough et al., 2005; Rintoul et al., 2003; Yi et al., 2004) . Ca 2+ sensing involves the helix-loop-helix structural domain (EF) hands of the Miro proteins (MacAskill et al., 2009b; Saotome et al., 2008; Wang and Schwarz, 2009) . Mitochondria are also a major site for production and scavenging of reactive oxygen species (ROS) that serve as both a mediator and a regulator of calcium signaling and are relevant for the control of mitochondrial function. Numerous studies have described ROS-induced changes in mitochondrial shape and distribution (Das et al., 2012; De Vos et al., 2007; Fang et al., 2012; Magrané et al., 2014; Morfini et al., 2013) , but these changes can result from a variety of different mechanisms, and the effect of ROS on mitochondrial movements has not been addressed yet.
Here, we tested the hypothesis that ROS target motility to control mitochondrial dynamics. Alteration of mitochondrial distribution can be detrimental for several tissues, in particular for neurons, where impairments of mitochondrial transport machinery result in neurological deficits (Guo et al., 2005; Mattson et al., 2008; Nguyen et al., 2014) (Gerencser and Nicholls, 2008) was applied to follow mitochondrial transport velocities, length, SH redox status of mitoroGFP1, and DJ M (Figure 1Aii -v). Velocities were measured using optical flow and also visualized by kymograms (Figure S1A) . To quantify motility, we averaged optical flow for all visible neurites for each observed neuron. Importantly, this approach allowed a low rate of imaging at 5 min intervals to minimize photoillumination-induced effects and to record multiple view fields cyclically, while velocities were calculated from a pair of frames recorded at each time point. Both H 2 O 2 (50 mM) and menadione (10 mM) triggered simultaneous oxidation of roGFP and a decrease in the mitochondrial motility (Figures 1A-1G ; Figures S1A-S1E). Increasing H 2 O 2 to 100 mM induced both higher oxidation and inhibition of mitochondrial velocity. When O 2 , À (generated by 5-14 mU/mL xanthine oxidase with 100 mM xanthine [X/XO]) was used as an oxidant, a decrease in motility was also observed (Figures 1D and 1I) . Treatment with X/XO had a strong oxidative property ( Figure 1E ) but was less effective than H 2 O 2 in inhibiting mitochondrial transport. To control for cell viability, we measured plasma membrane potential (DJ p ) in separate experiments by an anionic plasma membrane potential indicator (PMPI) (Nicholls, 2006 ) and intracellular [Ca 2+ ] by rhod2 (under our conditions, rhod2 compartmentalized mostly to the cytoplasm) (Figures S1G and S1H) . DJ p did not depolarize in the first 2 hr of the exposure to H 2 O 2 (100 mM) and menadione (10 mM). [Ca 2+ ] c did not elevate for 90 min in the presence of H 2 O 2 , while it slightly but gradually increased with menadione.
Inhibition of Mitochondrial Motility and Mitochondrial
Elongation Induced by ROS Are Triggered Independently Mitochondrial fusion-fission dynamics and movements are mutually coupled (Liu et al., 2009; Mouli et al., 2009 Figure S1I ). In contrast to shape changes, the inhibitory effect on mitochondrial motility was universal and early for H 2 O 2 , X/XO, and menadione treatments for all used concentrations.
To investigate the temporal relationship of the loss of motility, shape changes, and DJ m , we plotted the parameters shown in Figures 1D, 1F , and 1G against each other pairwise ( Figure 1H ; Figures S1J and S1K). In Figure 1H , the measured properties gradually deviate from the baseline (''start,'' 100% velocity and length) as the experiment progresses to the ''end'' (t = 120 min). H 2 O 2 (50-100 mM) and X/XO (14 mU/mL) treatments resulted in a characteristic track in the velocity-length (legend continued on next page) diagram indicating initial motility inhibition with elongation, followed by further deceleration of mitochondria with shortening. Remarkably, X/XO (5 mU/mL) and myxothiazol + oligomycin treatments (used to specifically depolarize DJ m by inhibiting complexes III and V of the oxidative phosphorylation) caused instead partial deceleration with shortening, whereas menadione distinctly triggered partial deceleration with marked elongation. Figure S1J shows that the deceleration caused by specific DJ m depolarization by myxothiazol + oligomycin was far less in extent than the one caused by oxidants, when comparing them at identical potentials (e.g., at À10 mV depolarization). Notably, the myxothiazol + oligomycin-triggered shortening was probably due to swelling rather than fission as it was earlier shown (Gerencser and Nicholls, 2008; Yuan et al., 2007) . Figures S1J and S1K indicate that H 2 O 2 -and menadione-induced inhibition of motility preceded DJ m depolarization, when we consider that DJ p was relatively stable in this time period ( Figure S1I ). Notably, H 2 O 2 -induced DJ p hyperpolarization may mask a small extent of DJ m depolarization, but this was not the case for menadione. In contrast, the start of a gradual DJ m+p depolarization preceded shortening of mitochondria. Altogether, the different velocity-length temporal tracks triggered by the different oxidants follow independent trends, supporting the idea that the effectors modulating motility and mitochondrial fusion-fission are distinct molecular entities. Organelles To find out whether the ROS sensitivity of motility was a general cell mechanism and how it was mediated, we used H9c2 myoblasts because mitochondrial motility and its regulation by Ca 2+ have been studied in this model. Cells were transfected with mitoYFP, and mitochondrial movement response to H 2 O 2 addition was represented as kymograms in Figure S2A . The number of movement events significantly diminished 10 min after 200 mM H 2 O 2 addition and drastically dropped down at 20 min ( Figure S2B ), reproducing what was observed in rat hippocampal neurons.
To check the possibility that an ROS-induced [Ca 2+ ] c rise was the inducer of the motility decay, we next employed Ca 2+ -depleted H9c2 cells. Cells were pretreated with thapsigargin (Tg; 2 mM), an endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR) Ca 2+ -ATPase inhibitor, in a Ca 2+ -free extracellular medium to prevent intracellular Ca 2+ mobilization and the ensuing Ca 2+ entry. In these conditions, addition of 100 mM H 2 O 2 inhibited motility of mitochondria, which appeared almost all completely immobile after 8 min (540 s of time-lapse recording) as shown by the kymograms in Figure 2A . As expected, addition of 4 mM CaCl 2 at the end of the run (610 s) resulted in full inhibition of movements. The inhibitory effect of H 2 O 2 on mitochondrial transport in Ca
2+
-depleted conditions was also confirmed using the photoactivatable fluorescent protein technology (Eisner et al., 2014; Liu et al., 2009; Saotome et al., 2008) . Here, the mitochondrial matrix-targeted fluorescent protein is activated in small subregions of the cell, and subsequent time-lapse images show moving of individual mitochondria to other areas ( Figures S2C and S2D) . In control cells, mitochondria with photoactivated content appeared more and more distant from the photoactivation areas (see images of 540 and 720 s), whereas in cells treated with 100 mM H 2 O 2 , they remained confined to the photoactivation areas ( Figure S2C ). Furthermore, when the photoactivated fluorescence was plotted for the photoactivation areas, the time-dependent fluorescence decay was suppressed in H 2 O 2 -pretreated cells ( Figure S2D ). Thus, 100 mM H 2 O 2 inhibited mitochondrial transport in Ca 2+ -depleted conditions.
To confirm that no [Ca 2+ ] c change was caused by H 2 O 2 , we also loaded cells with fura-2-acetoxymethyl ester (fura-2 AM). Moving mitochondria are shown in the mitoYFP image as red and green pixels in which fluorescence between sequential images (12 s interval) was changing over an empirically determined threshold (Saotome et al., 2008; Yi et al., 2004 ] c . It was also present even at lower concentrations of H 2 O 2 , with the minimum effective concentration being 25 mM and a dosedependent trend (200 mM; 68% ± 0.8%, 100 mM; 60% ± 1.3%, 50 mM; 41% ± 1.8%, 25 mM; 30% ± 1.7%, 12.5 mM; 3.6% ± 2%; n = 8-10) ( Figures 2D and 2E) .
Because ROS exposure can cause broad changes in the cells, we tested whether H 2 O 2 also affected the transport of peroxisomes visualized by SKL-DsRed ( Figure 2F ). As for mitochondrial motility, SKL-DsRed-transfected H9c2 were Ca 2+ predepleted, and the time lapse was recorded in Ca 2+ -free extracellular medium. H 2 O 2 (100 mM) addition did not affect movements of peroxisomes as shown by kymograms at time point 540 s and by traces of motility decay in Figure 2G . As for mitochondria, addition of 4 mM CaCl 2 caused rapid decrease of peroxisomal motility. Thus, H 2 O 2 targeted mitochondrial motility without causing a broad organellar transport change.
H 2 O 2 can cause membrane damage that leads to cell death. To test whether this happened during the time course of our measurements, we used propidium iodide (PI) exclusion. In H9c2 cells (or MEFs used in some experiments later on), addition of H 2 O 2 (100 mM) failed to allow PI entry ( Figures S2E and S2F ). By contrast, digitonin, a detergent added at the end of the run, caused rapid intracellular accumulation of the dye.
Collectively, these results indicate that H 2 O 2 -induced targeting of mitochondrial motility is a general cell mechanism and it specifically impairs mitochondria movements, leaving peroxisomal motility or cell membrane integrity unaffected at least for the H 2 O 2 doses used here. dose-response relationship with the lowest effective concentration of 25 mM.
Endogenous ROS Induce a Decrease in Mitochondrial Motility
Next, effects of endogenously produced ROS were studied first by dampening the antioxidant defense. In hippocampal neurons, glutathione depletion by ethacrynic acid (Vesce et al., 2005) , CDNB ( Figure 1I ), or monochlorobimane (MCB; Figure S1F ) reduced mitochondrial motility similarly to oxidants. These findings were recapitulated in mitoYFP-expressing H9c2 cells. MCB becomes fluorescent when it conjugates with glutathione (GSH) in the cells (MCB F/F 0 ; 26.0 ± 0.7 versus 1.2 ± 0.0 of control; p < 0.01; Figure 3A) ; however, because GSH is major natural scavenger of H 2 O 2 , the formation of intracellular MCB-GSH rapidly depletes GSH, resulting in an increase in intracellular ROS (Vesce et al., 2005) . Upon MCB-GSH conjugation, a significant motility inhibition was observed (72.5% ± 0.9% versus 15.4% ± 0.9% of control; n = 7; p < 0.01; Figure 3B ). Thus, an intracellular ROS source could reproduce the inhibitory effect on motility observed by externally administering H 2 O 2 .
To test whether mitochondrial motility was affected even when intracellular ROS were restricted to a small area of the cell, we loaded mitoYFP-expressing H9c2 cells with MitoTracker Red-CMXRos (MTR) and used photoillumination to generate localized intracellular ROS elevation ( Figure 3C ). Kymograms and plots of motility show a rapid and drastic effect on motility in the area of photoillumination (Figure 3D) . To test whether photoillumination per se was exerting an inhibitory effect on motility, we counted the number of immobile mitochondria also in the adjacent area of the cell ( Figure 3E ). In the photoilluminated area, the number of immobile mitochondria was increased to 86.7%. In the area adjacent to the site of ROS generation, inhibitory effect was still present, even if with a lesser extent (34.8%). As a control, immobile mitochondria were counted in an area far away from the photoilluminated one, and no inhibition of mitochondrial motility was observed (Figure 3E) . To further validate the role of ROS in photoillumination-induced motility inhibition, we pre-incubated cells with a scavenger, Mn(III) tetrakis (N-ethylpyridinium-2-yl) porphyrin (MnTE-2-PyP) ( Figure 3E mimetic resulted in attenuation of the photoillumination-induced motility inhibition, with a decrease in the number of immobile mitochondria of almost half of non-treated cells in the photoilluminated area and also in the adjacent area (from 34.5% to 5.1%). Thus, when ROS is produced in a cellular subregion, the motility inhibition is also spatially confined, suggesting that ROS can serve as a local factor in the control of motility.
Neither Mitochondrial PTP Opening nor DJ m Loss Is Required for H 2 O 2 -Induced Mitochondrial Motility Inhibition In mammalian cells, directional mitochondrial movements usually take place along microtubules. We therefore investigated whether ROS affected the spatial organization of mitochondria relative to microtubules. In Figure S3A , the confocal images of mitoDsRed and tubulin GFP co-transfected cells revealed that H 2 O 2 did not evoke any change in the spatial relationship between mitochondria and microtubules ( Figure S3A) .
A main mitochondrial target of oxidative stress is the PTP, the opening of which commonly causes mitochondrial dysfunction (Rasola and Bernardi, 2011) . Therefore, next it was investigated whether PTP is involved in the ROS-induced motility inhibition. Pre-incubation with the selective PTP inhibitor Me-Val-CSA (mCsA; 5 mM) did not suppress the ROS-dependent mitochondrial motility inhibition ( Figures 3C, right panel, and 3D ). The broad PTP/calcineurin inhibitor cyclosporine A (CsA) was also applied to Ca 2+ -depleted cells, and the H 2 O 2 -induced motility decay was evaluated ( Figures S3B and S3C ). CsA did not alter the H 2 O 2 -induced motility inhibition (64.8% ± 1.3% H 2 O 2 alone versus 60.9% ± 1.3% of H 2 O 2 +CsA; n = 37; Figure 3E ), confirming that PTP opening was not involved in the phenomenon.
In hippocampal neurons, H 2 O 2 and menadione inhibited motility before loss of DJ m , and in a greater extent than specific discharging of DJ m did. To further test the relationship between H 2 O 2 -induced motility inhibition and depolarization, we measured DJ m in Ca 2+ -depleted H9c2 cells. H 2 O 2 did not alter DJ m , at least when the motility inhibition became apparent (Figure S3D) . In FCCP-and oligomycin-treated cells, dissipation of DJ m was gradually followed by the loss of motility, reflecting the slower kinetic of cytoplasmic ATP depletion (Yi et al., 2004) ( Figure S3E ). However, even during the uncoupler-induced depolarization, H 2 O 2 caused further inhibition in motility (79.4% ± 1.3% versus 62.4% ± 1.2% of control; n = 21; p < 0.01; lower plot in Figure S3E ), supporting that H 2 O 2 suppressed motility independent of DJ m loss.
H 2 O 2 -Induced Mitochondrial Motility Inhibition Is a Reversible Process
Mitigation of endogenous H 2 O 2 was increasing mitochondrial motility in neurons where N-acetyl-cysteine was applied, resulting in increased mitochondrial velocities after 40 min ( Figure 1I ). To further assess the effects of antioxidants on H 2 O 2 -induced mitochondrial motility inhibition in H9c2 cells, we incubated the Ca 2+ -depleted cells with H 2 O 2 , and after the mitochondrial motility inhibition was documented (5 min), the extracellular H 2 O 2 was eliminated by catalase (2,500 IU) and motility was reassessed at 20 min. As shown in Figure 4A , catalase treatment reversed H 2 O 2 -induced motility decrease (96.4% ± 5.5% of motility in treated versus 78.4% ± 4.4% in untreated). Again, treatment with CsA has no effect on the motility inhibition and its reversibility ( Figure 4B ), arguing against a role of PTP activation in the process. p38a Is Required for the H 2 O 2 -Induced Mitochondrial Motility Inhibition H 2 O 2 was reported to induce many changes in protein phosphorylation and activation of signaling factors mediating phosphoregulation like protein kinase C (Shibukawa et al., 2003) , protein phosphatase 2A (PP2A) (Rao and Clayton, 2002) , and mitogen-activated protein kinases (MAPKs) superfamily through activation of ASK1 MAP3 kinase ( Figure 4C ) (Ichijo et al., 1997; Saitoh et al., 1998) . To evaluate whether any of these pathways were involved here, we screened kinase and phosphatase inhibitors for motility regulation in the presence of H 2 O 2 . Neither okadaic acid (PP1 and PP2A inhibitor) nor staurosporine (PKC inhibitor) was able to influence on motility inhibition by H 2 O 2 . To selectively inhibit JNK or p38 MAPK kinases, we used SP600125 or SB202190 in a Ca 2+ -free condition. H 2 O 2 was able to decrease motility in both kinase inhibitor untreated and SP600125-treated cells, but it was ineffective when SB202190 was used ( Figure 4D ), suggesting an involvement of p38. Four isoforms of p38 exist in mammals (a, b, d, and g). In the heart, all four isoforms are present (Dingar et al., 2010) . However, in the brain and many other tissues, only p38a and p38b are expressed (Jiang et al., 1996; Stein et al., 1997) . Interestingly, p38 phosphorylation has recently been implied in the regulation of ER-mitochondria associations and motility (Li et al., 2015) , and activation of p38a inhibits anterograde fast axonal transport upon expression of a pathogenic mutation of superoxide dismutase 1 (SOD1) (Morfini et al., 2013) . To test whether isoform a could play a role in motility regulation, we transfected H9c2 with a dominant-negative mutant of p38a (p38a DN ), in which Thr180 and Tyr182 residues were mutated to prevent phosphorylation and activation of the MAPK. Dominant-negative interference with p38a also rendered mitochondrial motility gradually declining in our recording conditions (21% ± 3% of motility decay; Figure S2A ). H 2 O 2 suppressed the remaining motility to a smaller extent in p38a DN -expressing cells than in cells transfected with empty vector (EV; Figure 4E ).
was able to decrease motility in both kinase inhibitor untreated and SP600125-treated cells, but it was ineffective when SB202190 was used (% of motility decay of 25 ± 4, 29 ± 4 and 4 ± 3, respectively). *p < 0. MEFs did not cause a decrease of localized mitochondrial movements ( Figure 4F ) or general mitochondrial motility inhibition (Figure 4G) , confirming that p38a is required for the H 2 O 2 -induced motility arrest.
The Motor Adaptor Complex Is Essential for Mediating the H 2 O 2 -Induced Mitochondrial Motility Decay
Mitochondrial movements along microtubules and microfilaments are achieved through an adaptor complex (containing Miro1/2 and Trak1/2) and motor proteins (kinesins, dyneins, and myosins). Because the spatial relationship between mitochondria and microtubules is not affected by H 2 O 2 ( Figure 2G ), we reasoned that the activity of one of these two components could be the target of p38 for achieving ROS-induced inhibition of motility. Kinesin KIF5C has been already described as a target of p38 (Morfini et al., 2013) : phosphorylation of its serine residue in position 176 regulates cargo transport by promoting disengagement of the motor from microtubule tracks (Padzik et al., 2016) . Kif5B, one of the kinesins responsible for movements of mitochondria (Tanaka et al., 1998) , together with Kif1B and KLP (Nangaku et al., 1994; Tanaka et al., 2011) , belongs to the same kinesin family as Kif5C (Kanai et al., 2000) . Serine 176 is conserved between KIF5C and KIF5B, and is also found in KIF1B ( Figure S4C ). We therefore created a phospho-resistant mutant of KIF5B by mutagenizing residue 176 to alanine (KIF5B
S176A
) and used it to transfect H9c2 cells ( Figure S4D ). After exposure to H 2 O 2 , H9c2 expressing the phospho-resistant mutant of KIF5B exhibited approximately the same percentage of motility decay documented in control cells (55.7% ± 2% for KIF5B S176A and 60.3% ± 2% for EV-transfected cells; Figure S4E ). Therefore, expression of phospho-resistant KIF5B S176A was unable to prevent mitochondrial motility inhibition exerted by H 2 O 2 . This kinesin in combination with the FRB-FKBP drug-inducible heterodimer was then employed to determine the involvement of Miro/Trak protein complex in the effect exerted by H 2 O 2 . HA-KIF5B (1-807)-FRB, the truncated KIF5B lacking its tail domain, which is known to be constitutively active without interference of regulatory pathways (Kapitein et al., 2010) , was fused to FRB and was co-expressed with TOM20-mCherry-FKBP (Chung et al., 2016) . Addition of rapalog causes heterodimerization between adjacent FRB and FKBP domains to directly connect kinesin motor proteins to mitochondria. The rearrangement of mitochondrial distribution upon rapalog addition is shown in Figure 5A : mitochondria initially accumulated around the nucleus (150 s) aligned with the microtubular tracks (240 s; see also Figure S4F ), where Kif5B is probably anchored, and then move to the peripheral tips of the cell, where they form aggregates (600 s, arrowheads, lower right panel). Cells untreated with rapalog did not show any change in the mitochondrial distribution during the same time ( Figure 5A , upper panel).
To assess whether the rapalog-induced anchoring to Kif5B was affecting motility, we quantified the amount of moving mitochondria (represented as red and green pixels, Figure 5B) . Expression of the anchor components, in the absence of rapalog, did not substantially change it ( Figure 5B, first row) . In the same condition, H 2 O 2 caused a decrease in mitochondrial motility (second row). However, when mitochondria were directly anchored to KIF5B, H 2 O 2 was unable to induce a decrease in the motility ( Figures 5B, last two rows, 5C, and 5D ). Mean traces of the motility decay for the conditions described above are shown in Figure 5C . These data suggest that H 2 O 2 targets the motor adaptor complex via p38a to suppress mitochondrial movements.
DISCUSSION
This work provides evidence for the control of mitochondrial motility by ROS, through a p38a-dependent pathway and the adaptor complex that anchors mitochondria to the microtubular motor proteins. Both external and internal sources of ROS cause a decrease in mitochondrial motility in rat hippocampal neurons and H9c2 cells. This is attained by small amounts of ROS like 25 mM H 2 O 2 and is rapidly reversible. ROS can stop mitochondrial movements independent of [Ca 2+ ] c , a well-known mitochondrial motility regulator, and of Dc m . Furthermore, ROS-induced mitochondrial dysfunction or PTP opening is not involved in H 2 O 2 -induced motility decay. Based on genetic and pharmacological evidence, ROS inhibition of mitochondrial motility requires a p38a pathway and seems to target specifically the adaptor complex that links mitochondria to the microtubular motor proteins. Due to their polarized and complex functional and structural organization, neurons need to distribute mitochondria in neurites, to reach areas where their metabolic activity is required (like synapses) and to easily drive their engulfment and elimination and replacement when they become dysfunctional during cellular stress. ROS function as intracellular messengers in long-term potentiation but also represent a source of synaptic stress, when their elevation is sustained. We here showed that oxidative stress (H 2 O 2 , O 2 , À , menadione, and GSH depletion) rapidly suppresses mitochondrial velocity in rat hippocampal neurons in a dose-dependent manner. Importantly, inhibition of motility was distinguished from ROS-induced mitochondrial elongation and fragmentation, which are evoked by prolonged/ massive ROS exposure. We have studied the mechanism of the motility inhibition (see below) and speculate that a separate ROS-activated pathway engages the mitochondrial fusionfission proteins likely by posttranslational modification, but establishing this point requires further studies.
To investigate the mechanisms underlying the ROS-induced mitochondrial motility inhibition, we switched to H9c2 cells that we had extensively used in previous works to dissect mitochondrial dynamics. ROS likely target functionally relevant SH groups in proteins, but the number of candidate proteins is high. We considered three potential mechanisms to decrease mitochondria motility in response to ROS. 
2016
) and through modulation of ER or plasma membrane Ca 2+ transport mechanisms (Bootman et al., 1997; Csordá s and Hajnó czky, 2009; Prosser et al., 2011 -induced motility arrest could involve ROS. Ca 2+ can increase ROS generation by enhancing tricarboxylic acid cycle and making the mitochondrial redox centers more reduced (Brand, 2016; Hansford and Zorov, 1998; McCormack and Denton, 1993) and by opening the PTP (Vercesi et al., 1997) . However, we have shown that Ca 2+ does not have to enter mitochondria to control motility (Yi et al., 2004) . Ca 2+ could also act on extramitochondrial enzymes like NADPH oxidase, cytochrome P450, xanthine oxidase, cyclooxygenase, and lipoxygenase to enhance ROS (Kevin et al., 2003; Sauer et al., 2001) , or on mitochondria externally, by activating reductive equivalent shuttles (Orr et al., 2012 with the adaptor/motor complex (MacAskill et al., 2009b; Saotome et al., 2008; Wang and Schwarz, 2009; Yi et al., 2004) . Thus, Ca 2+ and ROS seem to have privileged mechanisms to target mitochondrial motility, but they can also engage each other to regulate motility. The next potential candidates to mediate ROS-induced mitochondrial motility inhibition were PTP opening and loss of the mitochondrial membrane potential, because they have been shown to be outcomes of oxidative stress (De Vos et al., 2007; Rasola and Bernardi, 2011) . But neither PTP inhibition nor predissipation of the membrane potential prevented the H 2 O 2 -induced motility inhibition.
Lastly, we considered that many effects of ROS are relayed to changes in protein phosphorylation, and we employed first a pharmacological approach to test the possible involvement of protein kinases and phosphatases. From the drugs tested, only SB202190, an inhibitor of p38, attenuated the motility decay caused by H 2 O 2 . However, SB202190 has been reported to stimulate ruthenium red-sensitive mitochondrial Ca 2+ uptake in both p38-dependent and -independent manners (Montero et al., 2002; Szanda et al., 2008) . Therefore, we used two independent genetic models to verify whether p38a was involved in the process of H 2 O 2 -induced mitochondrial motility inhibition:
(1) H9c2 cells were transfected with p38a DN , and (2) MEFs ablated of p38a were challenged with H 2 O 2 . Both sets of experiments demonstrated that p38a is required for the H 2 O 2 -induced motility decrease. In a previous work, SB202190-induced motility inhibition was ascribed to an increased mitochondrial Ca 2+ uptake (Chang et al., 2011) . However, we documented the H 2 O 2 -induced motility decrease in Tg-pretreated cells incubated in the absence of extracellular Ca 2+ , where no mitochondrial Ca 2+ uptake could occur. In addition, H 2 O 2 was unable to induce inhibition when p38 was targeted, suggesting that p38 activation in response to ROS might mediate the inhibition of the organellar movements. When mitochondria were forced to directly associate to a motor protein through a drug-induced FRB-FKBP tether, the effect of H 2 O 2 on motility was prevented, suggesting that ROS target the adaptor complex. Phosphorylation of mitochondrial and cytosolic substrates has been recently proposed as the mechanism that drives redistribution of mitochondria during mitosis (Chung et al., 2016) . In that study, phosphorylation drives detachment of mitochondria + adaptor from motor protein. However, we did not document a change in the association of mitochondria to microtubules upon ROS elevation. This observation is also an argument against switching of mitochondria to microfilaments or intermediate filaments, which also support mitochondrial positioning (Kuznetsov et al., 1992; Nekrasova et al., 2011; Pathak et al., 2010; Schwarz and Leube, 2016) . Alternative explanations are that the adaptor might respond to ROS and p38a activation by relaying an inhibitory signal to the motor proteins or by binding to less active motor proteins.
Mitochondrial motility inhibition is induced by physiologically relevant doses of H 2 O 2 and is rapidly reversed by removal of H 2 O 2 . This supports the idea that ROS might work as a physiological regulator of mitochondrial distribution, temporally decelerating the organelles when and where it is required. This process may enable to recruit additional mitochondria at the site of ROS elevation, and serve both ROS scavenging and propagation of ROS production, which may have relevance in pathophysiological conditions. Finally, in line with recent findings on ROS/Ca 2+ communication at mitochondria-ER contact sites (Booth et al., 2016) and on the involvement of mitochondrial respiratory complex I-and III-originated ROS in ER-stress-induced caspase activation , a Ca 2+ -induced rise in mitochondrial ROS could serve as a signal to stop mitochondria in proximity to ER to establish new contact sites to serve as signaling modulators. Thus, our findings offer some clues relevant for mitochondrial quality control and for both cell survival and death signaling.
In the final phase of the writing of this manuscript, a paper came out on oxidative stress (paraquat and H 2 O 2 )-induced motility inhibition in fly neurons (Liao et al., 2017) . Thus, ROS control motility both in fly and in mammalian cells, although in fly, the ROS effect seems to be mediated via [Ca 2+ ] c elevation, whereas in mammalian cells, ROS can engage robust motility inhibition even independent of Ca 2+ . Liao et al. (2017) speculated that elevated [Ca 2+ ] c acts through Miro1, a mitochondrial anchor for motors, and we provided experimental evidence that the motor adaptor complex is needed for the inhibitory effect of ROS. Interestingly, in fly, JNK was also implicated in the motility inhibition, whereas in mammalian cells, p38a is required and JNK is dispensable. p38a is present in fly but was not investigated by Liao et al. (2017) . From the two studies, an evolutionarily conserved ROS phenotype emerges in motility that uses species-specific underlying mechanisms to target the mitochondrial motor adaptor complex. 
Fluorescence and Confocal Imaging
Time-lapse fluorescence microscopy of hippocampal neurons was performed on an Olympus IX81, while measurements [Ca 2+ ] c and/or mitochondrial motility in H9c2 and MEFs were carried out on an Olympus IX70 with UAPO 403 oil 1.3 NA lens. Confocal imaging was performed using a Radiance 2100 (Bio-Rad).
Evaluation of Mitochondrial Motility
Mitochondrial velocities were measured as optical flow (Gerencser and Nicholls, 2008) , whereas motility in H9c2 cells and MEFs was evaluated as described previously (Saotome et al., 2008; Yi et al., 2004) .
Statistical Analysis
All experiments were performed with at least three different preparations. Data are presented mean ± SEM, and significance of difference was calculated by t test unless otherwise indicated. For measurements of mitochondrial velocities in neurons, nine cells were pooled from each preparation, and the results were tested using ANOVA (Dunnett's post hoc test, treatment versus control, independently for the two time points). For measurements of DJ p in neurons, data are % of baseline fluorescence (n = 81, 107, and 70 cells for control, H 2 O 2 , and menadione, respectively). For measurements of mitochondrial motility in H9c2 cells and MEFs for each condition, 7-10 cells/preparation were evaluated. 
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